Amrize (NYSE:AMRZ) Sets New 1-Year Low - What's Next?

Key Points

• Amrize shares hit a new 52-week low, trading as low as $39.42 and closing around $39.50, well below the 50-day and 200-day moving averages.
• Analyst sentiment has weakened, with several firms cutting ratings and price targets; the stock carries a consensus “Hold” rating and an average target of $55.50.
• The company missed quarterly earnings estimates, reporting $0.88 in EPS versus $0.92 expected, though insiders—including the CEO—have recently purchased shares and Amrize continues to pay a quarterly dividend.

Amrize Ltd (NYSE:AMRZ - Get Free Report)'s stock price reached a new 52-week low on Tuesday . The company traded as low as $39.42 and last traded at $39.4990, with a volume of 3738542 shares changing hands. The stock had previously closed at $40.52.

Analysts Set New Price Targets

A number of research analysts recently commented on AMRZ shares. Zacks Research cut Amrize from a "hold" rating to a "strong sell" rating in a research report on Wednesday, August 19th. JPMorgan Chase & Co. cut shares of Amrize from an "overweight" rating to a "neutral" rating and cut their price objective for the stock from $57.00 to $52.00 in a research report on Wednesday, September 2nd. DA Davidson began coverage on shares of Amrize in a research report on Monday, August 24th. They issued a "neutral" rating and a $50.00 target price for the company. Wells Fargo & Company reaffirmed an "equal weight" rating and set a $44.00 price target (down from $55.00) on shares of Amrize in a report on Wednesday, September 9th. Finally, Royal Bank Of Canada lowered shares of Amrize from a "sector perform" rating to an "underperform" rating and reduced their price target for the stock from $60.00 to $48.00 in a research report on Monday, August 10th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, eight have issued a Hold rating and four have given a Sell rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $55.50.

Amrize Stock Performance

The company has a debt-to-equity ratio of 0.33, a current ratio of 1.10 and a quick ratio of 0.73. The stock has a 50-day simple moving average of $46.94 and a 200-day simple moving average of $52.27. The stock has a market cap of $21.85 billion, a P/E ratio of 18.20, a PEG ratio of 1.20 and a beta of 0.04.

Amrize (NYSE:AMRZ - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing analysts' consensus estimates of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The firm had revenue of $3.49 billion during the quarter. Research analysts forecast that Amrize Ltd will post 2.67 earnings per share for the current year.

Amrize Announces Dividend

The company also recently announced a dividend, which was paid on Wednesday, August 26th. Shareholders of record on Tuesday, August 18th were issued a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, August 18th. Amrize's dividend payout ratio is presently 20.28%.

Insider Transactions at Amrize

In related news, CEO Jan Jenisch bought 26,000 shares of the stock in a transaction that occurred on Wednesday, September 2nd. The stock was acquired at an average cost of $42.47 per share, with a total value of $1,104,220.00. Following the transaction, the chief executive officer directly owned 1,767,000 shares in the company, valued at approximately $75,044,490. This trade represents a 1.49% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Stephen S. Clark purchased 5,260 shares of the company's stock in a transaction dated Tuesday, August 11th. The stock was purchased at an average price of $47.31 per share, for a total transaction of $248,850.60. Following the transaction, the insider directly owned 10,637 shares in the company, valued at approximately $503,236.47. This trade represents a 97.82% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders purchased 48,983 shares of company stock valued at $2,158,755. 0.54% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Amrize

A number of institutional investors and hedge funds have recently modified their holdings of the business. MCF Advisors LLC acquired a new position in shares of Amrize during the fourth quarter worth approximately $27,000. Basepoint Wealth LLC bought a new position in shares of Amrize in the 4th quarter worth $33,000. Continuum Advisory LLC acquired a new stake in Amrize in the 2nd quarter valued at $62,000. NewEdge Advisors LLC grew its position in Amrize by 1,419.7% in the 2nd quarter. NewEdge Advisors LLC now owns 2,082 shares of the company's stock valued at $111,000 after purchasing an additional 1,945 shares during the period. Finally, Oslo Pensjonsforsikring AS bought a new stake in Amrize during the 1st quarter valued at $133,000.

Amrize Company Profile

Amrize is a North American building materials and solutions company formed through the separation of Holcim's North American business. The company began trading publicly on the New York Stock Exchange in 2025 under the symbol AMRZ.

Amrize supplies essential construction materials, including cement, aggregates, ready-mix concrete and asphalt. It also provides a range of building products and solutions used in residential, commercial and infrastructure construction, including concrete products, roofing systems and other materials designed to support building and construction projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution operations and local businesses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.